Yao Ho is a Managing Director at LYFE Capital. Prior to joining LYFE Capital, he led various Business Development and Corporate Development projects at Yangtze River Pharmaceutical Group. Being American-born, but fluent in multiple languages, Yao was one of the early professionals that devoted himself to Asia-US value creation opportunities in the healthcare industry. Through his 15 years of experience, he has obtained profound understanding in the demands of Asian/US CEOs and has accumulated experience in value creation across LYFE portfolio companies. Yao received his MBA from Tsinghua University in partnership with MIT and was initially trained as a biomedical engineer at UC-Irvine.